A Phase 1 Study of ABBV-453 in Adult Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Clinical Trial Grant
Awarded By
AbbVie Inc.
Start Date
March 7, 2025
End Date
February 10, 2026
Awarded By
AbbVie Inc.
Start Date
March 7, 2025
End Date
February 10, 2026